# Understanding the Spectrum of ENPP1 Deficiency and Acute ABCC6 Deficiency

> **NCT04372446** · — · COMPLETED · sponsor: **Inozyme Pharma** · enrollment: 38 (actual)

## Conditions studied

- Generalized Arterial Calcification in Infancy
- Autosomal Recessive Hypophosphatemic Rickets Type 2

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04372446
- **Lead sponsor:** Inozyme Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-06
- **Primary completion:** 2020-09-30
- **Final completion:** 2020-09-30
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2021-04-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04372446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04372446, "Understanding the Spectrum of ENPP1 Deficiency and Acute ABCC6 Deficiency". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04372446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*